These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 11366698)
21. Recent FDA approvals and changes. AIDS Patient Care STDS; 2010 Aug; 24(8):528. PubMed ID: 20712509 [No Abstract] [Full Text] [Related]
22. Retrovir efficacy supplement approved. AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043841 [No Abstract] [Full Text] [Related]
23. FDA notifications. FDA grants approval of generic lamivudine tablets. AIDS Alert; 2009 Dec; 24(12):142-3. PubMed ID: 20063478 [No Abstract] [Full Text] [Related]
24. 3TC approval may revive AZT's appeal. Vazquez E Posit Aware; 1996; 7(1):8-9. PubMed ID: 11363136 [TBL] [Abstract][Full Text] [Related]
25. FDA notifications. FDA approves generic combination of efavirenz, lamivudine & tenofovir. AIDS Alert; 2009 Nov; 24(11):130. PubMed ID: 19960612 [No Abstract] [Full Text] [Related]
26. FDA panel backs Glaxo Wellcome drug for use in treating chronic hepatitis B. Food and Drug Administration. Newsline People AIDS Coalit N Y; 1998; ():32. PubMed ID: 11367504 [TBL] [Abstract][Full Text] [Related]
27. Combo therapy for children and adolescents. Treat Rev; 1997 Aug; (No 25):7. PubMed ID: 11364620 [TBL] [Abstract][Full Text] [Related]
28. FDA notifications. FDA approval for generic lamivudine/zidovudine. AIDS Alert; 2008 Jan; 23(1):12. PubMed ID: 18572476 [No Abstract] [Full Text] [Related]
29. FDA notifications. Generic abacavir and lamivudine combo approved. AIDS Alert; 2008 Oct; 23(10):115. PubMed ID: 18935685 [No Abstract] [Full Text] [Related]
30. FDA notifications. Tentative approval given for combination of abacavir, lamivudine & zidovudine tablets. AIDS Alert; 2009 Sep; 24(9):106. PubMed ID: 19928326 [No Abstract] [Full Text] [Related]
31. Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1. Krogstad P; Lee S; Johnson G; Stanley K; McNamara J; Moye J; Jackson JB; Aguayo R; Dieudonne A; Khoury M; Mendez H; Nachman S; Wiznia A; Clin Infect Dis; 2002 Apr; 34(7):991-1001. PubMed ID: 11880966 [TBL] [Abstract][Full Text] [Related]
32. Viramune (Nevirapine) is approved for children. Vazquez E Posit Aware; 1998; 9(6):17. PubMed ID: 11366470 [TBL] [Abstract][Full Text] [Related]
33. HIV drug now approved for use with protease inhibitors. Nurse Pract; 1998 Oct; 23(10):89. PubMed ID: 9805335 [No Abstract] [Full Text] [Related]
34. FDA notifications. Tentative approval for fixed-dose combo abacavir/lamivudine. AIDS Alert; 2009 Feb; 24(2):22. PubMed ID: 19219952 [No Abstract] [Full Text] [Related]
35. Delavirdine (Rescriptor) approved. James JS AIDS Treat News; 1997 Apr; (No 269):1-3. PubMed ID: 11364252 [TBL] [Abstract][Full Text] [Related]
36. FDA notifications. Tentative approval of generic lamivudine. AIDS Alert; 2005 Jul; 20(7):82. PubMed ID: 16114112 [No Abstract] [Full Text] [Related]
37. Diminished selection for thymidine-analog mutations associated with the presence of M184V in Ethiopian children infected with HIV subtype C receiving lamivudine-containing therapy. Averbuch D; Schapiro JM; Lanier ER; Gradstein S; Gottesman G; Kedem E; Einhorn M; Grisaru-Soen G; Ofir M; Engelhard D; Grossman Z Pediatr Infect Dis J; 2006 Nov; 25(11):1049-56. PubMed ID: 17072129 [TBL] [Abstract][Full Text] [Related]
38. FDA approves 3TC and saquinavir. Food and Drug Administration. Baker R BETA; 1995 Dec; ():5, 9. PubMed ID: 11363011 [TBL] [Abstract][Full Text] [Related]
39. FDA approves three generics. AIDS Patient Care STDS; 2009 Apr; 23(4):305. PubMed ID: 19358692 [No Abstract] [Full Text] [Related]
40. FDA notifications. Tentative approval for lamivudine. AIDS Alert; 2009 Aug; 24(8):93-4. PubMed ID: 19708084 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]